OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Bone Marrow Mesenchymal Stem Cell-Derived Extracellular Vesicle Infusion for the Treatment of Respiratory Failure From COVID-19
Amy L. Lightner, Vikram Sengupta, Sascha Qian, et al.
CHEST Journal (2023) Vol. 164, Iss. 6, pp. 1444-1453
Open Access | Times Cited: 53

Showing 26-50 of 53 citing articles:

mRNA-based vaccines and therapies - a revolutionary approach for conquering fast-spreading infections and other clinical applications: a review
Mingyue Pan, Weiling Cao, Jingbo Zhai, et al.
International Journal of Biological Macromolecules (2025), pp. 143134-143134
Closed Access

Mesenchymal Stem Cells on Mortality in COVID-19 Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Jinlv Qin, Guizuo Wang, Dong Han
Stem Cell Reviews and Reports (2024) Vol. 20, Iss. 4, pp. 931-937
Closed Access | Times Cited: 3

Manufacturing, quality control, and GLP-grade preclinical study of nebulized allogenic adipose mesenchymal stromal cells-derived extracellular vesicles
Jing Wang, Zhong-jin Chen, Zeyi Zhang, et al.
Stem Cell Research & Therapy (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 2

Exosome nanovesicles: biomarkers and new strategies for treatment of human diseases
Chuan Xu, Chaoyang Jiang, Zhihui Li, et al.
MedComm (2024) Vol. 5, Iss. 8
Open Access | Times Cited: 2

Mesenchymal stem cells and their derived exosomes for the treatment of COVID-19
Xiang-Yi Hou, La-Mu Danzeng, Yilin Wu, et al.
World Journal of Stem Cells (2024) Vol. 16, Iss. 4, pp. 353-374
Open Access | Times Cited: 1

Bioengineering extracellular vesicle cargo for optimal therapeutic efficiency
Charlotte A. René, Robin J. Parks
Molecular Therapy — Methods & Clinical Development (2024) Vol. 32, Iss. 2, pp. 101259-101259
Open Access | Times Cited: 1

Amniotic fluid stem cell extracellular vesicles promote lung development via TGF-beta modulation in a fetal rat model of oligohydramnios
Fabian Doktor, Rebeca Lopes Figueira, Victoria Fortuna, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1

A Novel Extracellular Vesicle Paradigm for the Treatment of COVID-19 Induced Acute Respiratory Distress Syndrome (ARDS)
Erik Osborn, John Ransom, Anastasiya Shulman, et al.
Respiratory Medicine Case Reports (2024) Vol. 51, pp. 102087-102087
Open Access | Times Cited: 1

Trends in Developing Extracellular Vesicle-Based Therapeutics
Jaewook Lee
Brain Tumor Research and Treatment (2024) Vol. 12, Iss. 3, pp. 153-153
Open Access | Times Cited: 1

The role of mesenchymal stem cells in attenuating inflammatory bowel disease through ubiquitination
Hong Liao, Xiaojun Mao, Lan Wang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1

Unlocking the promise of mesenchymal stem cells and extracorporeal photopheresis to address rejection and graft failure in intestinal transplant recipients
Steven Levitte, Riya Nilkant, Amanda Jensen, et al.
Human Immunology (2024) Vol. 85, Iss. 6, pp. 111160-111160
Closed Access | Times Cited: 1

Application Potential of Extracellular Vesicles Derived From Mesenchymal Stem Cells in Renal Diseases
Enhui Li, Jia Xu, Ning Liu, et al.
Stem Cells (2023) Vol. 42, Iss. 3, pp. 216-229
Closed Access | Times Cited: 2

Bone marrow mesenchymal stem cell-derived extracellular vesicle infusion for amyotrophic lateral sclerosis
Joshua James Crose, Arezou Crose, John Ransom, et al.
Neurodegenerative Disease Management (2024) Vol. 14, Iss. 3-4, pp. 111-117
Closed Access

Research hotspots and emerging trends of mesenchymal stem cells in cardiovascular diseases: a bibliometric-based visual analysis
Zhihang Jiang, Jia‐Xin Yu, Houle Zhou, et al.
Frontiers in Cardiovascular Medicine (2024) Vol. 11
Open Access

Non-viral gene therapy for neuromuscular diseases including Duchenne muscular dystrophy using nanovesicles derived from human cells
Seung Wook Oh, Jinah Han, Sung‐Soo Park
Rare Disease and Orphan Drugs Journal (2024) Vol. 3, Iss. 4
Open Access

Therapeutic potential of mesenchymal stem cell‐derived extracellular vesicles in SARS‐CoV‐2 and H1N1 influenza‐induced acute lung injury
Jun Ho Lee, Hyungtaek Jeon, Jan Lötvall, et al.
Journal of Extracellular Vesicles (2024) Vol. 13, Iss. 9
Open Access

Targeting Cytokines: Evaluating the Potential of Mesenchymal Stem Cell Derived Extracellular Vesicles in the Management of COVID-19
Iago Carvalho Schultz, Ana Cláudia dos Santos Pereira Andrade, Isabelle Dubuc, et al.
Stem Cell Reviews and Reports (2024)
Closed Access

Das therapeutische Potenzial von extrazellulären Vesikeln von mesenchymalen Stromazellen
Tanja J. Kutzner, Fabiola Nardi Bauer, Bernd Giebel
Transfusionsmedizin (2024) Vol. 14, Iss. 04, pp. 190-199
Closed Access

Therapeutic potential of extracellular vesicles in inflammatory diseases
Xiaojian Huang, Shen Zhang, Zhenzhen Wang
Extracellular Vesicle (2024) Vol. 5, pp. 100058-100058
Closed Access

Scroll to top